Market Tracker

08/26 5:16pm ET

Amgen Inc (NASDAQ:AMGN)

171.97
Delayed Data
As of Aug 26
 +1.74 / +1.02%
Today’s Change
130.09
Today|||52-Week Range
176.64
+5.94%
Year-to-Date
Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection
Aug 25 / TheStreet.com - Paid Partner Content
3 Cheap Dividend Stocks You Can Buy Right Now
Aug 19 / MotleyFool.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex, Aurinia, AVEO and Amgen
Aug 18 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Aug 24 / Zacks.com - Paid Partner Content
Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled
Aug 18 / Zacks.com - Paid Partner Content
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
3 Reasons Medivation Is the Juiciest Target in Biotech
Aug 21 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close170.23
Today’s open170.80
Day’s range169.77 - 172.99
Volume2,925,290
Average volume (3 months)2,856,429
Market cap$127.4B
Dividend yield2.33%
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+9.46%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.6
Price/Sales5.83
Price/Book4.57

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.31-0.39%
BIIBBiogen+1.32+0.43%
BAXBaxter International...+0.08+0.17%
ILMNIllumina Inc+2.73+1.61%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts